Context: Recurrent hypoglycemia promotes impaired awareness, resulting in an increased risk for asymptomatic hypoglycemia. However, there are no firm data on the frequency of hypoglycemia in daily life needed to initiate this vicious cycle or the role of asymptomatic hypoglycemia.
H ypoglycemia is the main side effect of insulin therapy and can be disruptive and life-threatening in the daily life of persons with type 1 diabetes (T1D). Hypoglycemia can be classified as symptomatic or asymptomatic (silent) according to presence of warning symptoms. Furthermore, episodes of hypoglycemia are classified as severe if the patient needs assistance from another person to restore glucose levels to normal (1) . In T1D, hormonal counterregulatory responses to hypoglycemia are often impaired. The glucagon response usually becomes blunted in the years after diagnosis, and the catecholamine responses may be impaired along the course of disease, leading to counterregulatory failure with reduced endogenous glucose production during hypoglycemia. Therefore, warning symptoms of hypoglycemia are important for patients to detect and self-treat, thereby avoiding severe hypoglycemia. Antecedent episodes of hypoglycemia are known to blunt the catecholamine and symptomatic responses to hypoglycemia at subsequent episodes (2, 3) . Thus, recurrent hypoglycemia promotes the syndrome of impaired awareness of hypoglycemia with loss of warning symptoms in T1D. Impaired awareness of hypoglycemia is, in turn, known to increase the risk for severe hypoglycemia (4, 5) .
It is presumed that asymptomatic hypoglycemia is also implicated in this vicious cycle of recurrent hypoglycemia leading to impaired awareness (6) , but the exact manner by which events of asymptomatic hypoglycemia contribute to the cycle and the pathogenesis of impaired awareness is unclear. Asymptomatic hypoglycemia seems to be an important component in the syndrome of impaired awareness of hypoglycemia, as supported by two studies reporting that patients with impaired hypoglycemia awareness have the same frequency of mild symptomatic hypoglycemia but a higher rate of both asymptomatic hypoglycemia and severe hypoglycemia than patients with normal hypoglycemia awareness (7, 8) . However, there are no firm data on the frequency of daily-life hypoglycemia needed to initiate this cycle or on the exact role of asymptomatic hypoglycemia.
Therefore, using continuous glucose monitoring (CGM), we performed this study to investigate (1) the association between rate of hypoglycemic exposure and proportion of asymptomatic hypoglycemic events, (2) the association between the proportion of asymptomatic hypoglycemia and state of hypoglycemia awareness, and (3) the association between the proportion of asymptomatic hypoglycemia and the risk for severe hypoglycemia in T1D.
Materials and Methods

Participants
A cohort of patients with T1D attending the diabetes outpatient clinic at Nordsjaellands Hospital in Hillerød, Denmark, was recruited. All included participants were adults (age .18 years) with T1D for $1 year. Patients with end-stage renal disease, concomitant malignant disease, or pregnancy were excluded from participation in the study. The study was approved by the Regional Committee on Biomedical Research Ethics (H-15002715) and the Danish Data Protection Agency, and written informed consent was obtained from all participants before they entered the study.
Participants filled in a detailed questionnaire regarding selfestimated state of awareness according to the methods of Gold et al. (8) , Clarke et al. (9) , and Pedersen-Bjergaard et al. (10) , which are all validated methods for assessment of hypoglycemia awareness (11) . Furthermore, number of events of severe hypoglycemia in the preceding year was reported and defined as events with need of assistance from another person to actively restore glucose level to normal (1) .
Information about participants' history of diabetes, treatment, and late diabetic complications were also requested or extracted from the participants' medical records as appropriate. Hemoglobin A1c (HbA1c; Tosoh G8 HPLC Analyzer; Tosoh Bioscience Inc., San Francisco, CA) and C-peptide (Advia Centaur XP; Siemens Medical Solutions Diagnostics Inc., Los Angeles, CA) were measured, and participants with undetectable C-peptide levels (,20 pmol/L) were classified as C-peptide-negative.
Study setting
All participants underwent 6 days of blinded continuous interstitial glucose (IG) monitoring. The CGM system used in this study was iPro ® 2 CGMs using Enlite ™ Glucose Sensors (Medtronic MiniMed, Northridge, CA) [overall mean absolute relative difference of 13.9% and 18.4% in the hypoglycemic range; sensitivity of 79.5% and positive predictive value of 83.8% for hypoglycemia (12) ]. The CGMs were calibrated with blood glucose meter measurements (Contour ® XT meter using Contour ® NEXT test strips; Bayer, Basel, Switzerland) as recommended by the manufacturer (four times daily). While the monitoring was performed, participants carried out their daily life and treatment of diabetes as usual. During the monitoring period, the participants were instructed to fill in a diary about symptoms of hypoglycemia. We classified hypoglycemia as IG concentration below two threshold glucose values: #70 mg/dL [3.9 mmol/L (IG 70 )] and #54 mg/dL [3.0 mmol/L (IG 54 )] for $15 minutes (13-15) and recovery when the IG concentration had been continuously above the threshold for $20 minutes (13, 14) . Asymptomatic hypoglycemia was defined as an event of hypoglycemia without self-reported symptoms of hypoglycemia in the diary.
Statistical analyses
Because this was an exploratory study, no power calculation was made. Standard descriptive statistics were used to characterize participants. In those cases in which the distribution of data was skewed, medians and ranges are presented in addition to means and standard deviations.
The participants were grouped by number of hypoglycemic events during the recording period: group 0, no events; group 1, one event; group 2, two to three events; group 3, four to six events; group 4: seven or more events. Fraction of asymptomatic events was calculated in each group, and parametric (x Participants with no events (group 0) were excluded from the analyses.
We used the generalized estimating equation to assess the influence of risk factors on the risk for hypoglycemia so we could take into account patients who experienced more than one episode of hypoglycemia during the recording period. The logarithm of the recording period was used as offset in the model. A log-linear negative binomial regression model was used because this model takes into account the skewed distribution of episodes of hypoglycemia. The factors included in the analyses were fraction of asymptomatic hypoglycemia (per 10% increase), awareness of hypoglycemia, age (per 1-year increment), sex, C-peptide status, duration of diabetes (per 10 years), and HbA1c (per 10 mmol/mol).
We used the SPSS software package, version 22.0 (IBM, Armonk, NY) to analyses, and level of statistical significance was chosen as a P , 0.05 (two-sided).
Results
Participant characteristics are shown in Table 1 . Data on CGM recording were obtained from all 153 participants, and the total duration of recording was 22,621 hours, resulting in 22,500 hours of valid recording (99.5%) corresponding to 6.1 6 0.9 (mean 6 standard deviation) days of recording/participant.
Fraction of asymptomatic hypoglycemia
Threshold IG 70 At threshold IG 70 , 767 events of hypoglycemia were recorded by the 153 participants, resulting in an overall rate of hypoglycemia of 5.8 6 4.7 events/patient-week, which corresponds to 10.1 6 11.3 (median, 6.1; range, 0 to 65) hours in hypoglycemia/patient-week. The incidence of asymptomatic hypoglycemia was 4.3 6 4.2 events/patientweek, corresponding to 7.9 6 10.4 (median, 3.8; range, 0 to 65) hours in asymptomatic hypoglycemia/patientweek. Of the 153 participants, 133 (87%) had at least one event of hypoglycemia during the recording period, and these 133 participants are included in the following analyses. The overall fraction of asymptomatic hypoglycemia was 68% at threshold IG 70 . Across the four groups (Table 2) , the fraction of asymptomatic hypoglycemia increased: 57% in group 1, 61% in group 1, 65% in group 2, and 80% in group 4 (threshold IG 70 ). Figure 1 (a) displays the increase in rate of hypoglycemia from group 1 to group 4, separated by symptomatic and asymptomatic rates.
In univariate analyses, possible conventional risk factors of severe hypoglycemia were not significantly associated with severe hypoglycemia in this study. However, a high fraction of asymptomatic hypoglycemia was positively associated with the rate of severe hypoglycemia in the preceding 1-year period [incidence rate ratio (IRR), 1.3; 95% confidence interval (CI), 1.1 to 1.5; P = 0.003), whereas a high fraction of symptomatic hypoglycemia was negatively associated with the rate of severe hypoglycemia in the preceding 1-year period (IRR, 0.8; 95% CI, 0.7 to 0.9; P = 0.003). Adjustment for hypoglycemia awareness in the analyses did not change the results.
Threshold IG 54
At threshold IG 54 , 319 events of hypoglycemia were recorded by the 153 participants, resulting in an overall rate of hypoglycemia of 2.4 6 3.1 events/patient-week, which corresponds to 3.8 6 6.5 (median, 1.2; range, 0 to 43) hours with hypoglycemia/patient-week. The incidence of asymptomatic hypoglycemia was 1.8 6 2.7 events/patientweek, corresponding to 3.0 6 6.0 (median, 0.4; range, 0 to 43) hours with asymptomatic hypoglycemia/patient-week. Of the 153 participants, 133 (87%) had at least one event of hypoglycemia during the recording period, and these 133 participants were included in the following analyses (IG 54 ). At threshold IG 54 , the overall fraction of asymptomatic hypoglycemia was 71%. The fraction increased across the four groups: 64% in group 1, 70% in group 2, 75% in group 3, and 87% in group 4. Furthermore, the rate of asymptomatic episodes of hypoglycemia increased from 0.6 6 0.8 asymptomatic episodes/patientweek in group 1 to 1.6 6 1.0, 4.3 6 1.8, and 8.9 6 2.8 asymptomatic episodes/patient-week in groups 2, 3, and 4, respectively. The rate of symptomatic hypoglycemia increased less (rates of symptomatic hypoglycemia in groups 1, 2, 3, and 4 were 0.6, 1.0, 1.1, and 1.7 episodes/patientweek, respectively) [ Fig. 1(b) ]. Also at threshold IG 54 , there was a trend toward an association between higher fraction of asymptomatic hypoglycemia and increased risk for severe hypoglycemia, but it was not statistically significant (IRR, 1.1; 95% CI, 1.0 to 1.2; P = 0.076).
Characteristics of group 4 vs groups 1 through 3
The characteristics of group 4 having hypoglycemic events (threshold IG 70 ) on a daily basis were compared with the pooled data of groups 1 to 3 having less hypoglycemia and a lower proportion of asymptomatic hypoglycemia (Table 3) . Group 4 consisted of participants with longer duration of diabetes, lower HbA1c, and more frequently impaired awareness of hypoglycemia (assessed by the Hillerød and Clarke methods but not by the Gold method) as compared with groups 1 to 3. Age, sex, diabetes complications, and the proportion of C-peptide-negative participants did not differ between groups 1 through 3 and group 4.
Fraction of asymptomatic hypoglycemia and state of awareness of hypoglycemia
At threshold IG 70 , the fraction of asymptomatic hypoglycemia was higher in participants with impaired awareness and unawareness than in participants with normal awareness assessed by the Hillerød method [aware/impaired/unaware (percentage asymptomatic hypoglycemia): 63%/69%/90%; P = 0.01]. When the method of Clarke to assess state of awareness, we also found a higher fraction of asymptomatic hypoglycemia in participants with reduced awareness as compared with aware participants [aware/reduced awareness (percentage asymptomatic hypoglycemia): 63%/85%; P = 0.01], but not when using the Gold et al. method [aware/ impaired awareness (percentage asymptomatic hypoglycemia): 67%/74%; P = 0.25].
As shown in Fig. 2 , the overall rate of hypoglycemia tended to increase slightly but insignificantly (Hillerød method: P = 0.06; Gold method: P = 0.4; Clarke method: P = 0.1) with decreasing state of awareness. With decreasing awareness, the rate of asymptomatic hypoglycemia increased significantly as assessed by the Hillerød and Clarke methods (Hillerød method: P = 0.04; Gold method: P = 0.3; Clarke method: P = 0.01) and the rate of symptomatic hypoglycemia decreased according to the Hillerød method but not when assessed by the Clarke and Gold methods (Hillerød method: P = 0.03; Gold method: P = 0.4; Clarke method: P = 0.2).
Discussion
In a cohort of people with T1D, we found that three quarters of all episodes of hypoglycemia were asymptomatic. This finding supports findings in earlier studies in children and adolescents (16, 17) . To examine the association between the total occurrence of hypoglycemic events and the proportion of asymptomatic hypoglycemia, we subdivided the participants into four groups according to total number of hypoglycemic events during the recording period (excluding the 13% of the participants with no hypoglycemic episodes during the observation period of ;6 d/participant). The participants with a hypoglycemic rate corresponding to daily exposure to hypoglycemia (group 4) had a fraction of asymptomatic hypoglycemia of 80%, which is considerably higher than that in participants with less frequent hypoglycemic events. This is consistent with earlier studies showing that antecedent hypoglycemia blunts the response to subsequent episodes of hypoglycemia during the next 24 hours (3) but no longer (18) . These participants with daily exposure to hypoglycemia were characterized by longer duration of diabetes, lower HbA1c, and more frequent impaired awareness of hypoglycemia than participants with a rate of hypoglycemia corresponding to less than daily exposure, which are factors known to imply a risk of hypoglycemia (5, 13, 19, 20) . The increasing rate of hypoglycemia in the four groups was largely due to an increase in number of asymptomatic events of hypoglycemia rather than of symptomatic events. Thus, when the participants are exposed to hypoglycemia on a daily basis, the rate and fraction of asymptomatic hypoglycemia increase markedly, whereas the rate and fraction of symptomatic episodes are almost unchanged. This is consistent with our finding of an increasing proportion of asymptomatic hypoglycemia with decreasing awareness of hypoglycemia. Almost all (90%) of the hypoglycemic events were asymptomatic in participants with unawareness. Such a high proportion of asymptomatic hypoglycemia in patients with reduced awareness is of concern and supports our finding that higher fraction of asymptomatic hypoglycemia is the only significant predictor of severe hypoglycemia independent of state of hypoglycemia awareness. However, the lack of other significant risk factors of severe hypoglycemia could be explained by the low rate of severe hypoglycemia, thereby possibly making our cohort a low-risk cohort and making it difficult to assess the potential risk factors with sufficient statistical power. In a clinical setting, the positive association between higher proportion of asymptomatic hypoglycemia and risk for severe hypoglycemia raises the possibility of assessing patients' risk for severe hypoglycemia by determining the patients' proportion of asymptomatic hypoglycemia with CGM.
The positive association was found at threshold IG 70 , which may indicate that hypoglycemia defined at this threshold also contributes to the vicious cycle of recurrent hypoglycemia and impaired awareness as well as the clinically important events of hypoglycemia, recently redefined as glucose values ,54 mg/dL (15) . Our findings are in line with two previous studies exploring the relationship between state of hypoglycemia awareness and the frequency of symptomatic and asymptomatic hypoglycemia (7, 8) . Both studies used open daytime selfmonitored blood glucose to determining the rate of hypoglycemia and found that the frequency of asymptomatic hypoglycemia was fourfold (8) and sevenfold (7) higher in persons with T1D and impaired awareness as compared with persons with normal awareness at threshold IG 54 . However, the frequency of symptomatic hypoglycemia was the same and not related to state of awareness (7) .
In our study applying blinded CGM, the total amount of hypoglycemia tended to increase slightly as state of awareness decreased, but the increase was not statistically significant. However, the increase in proportion of asymptomatic hypoglycemia as state of awareness decreased was statistically significant and shows that it is an association. This is consistent with studies reporting decreased hormonal and symptomatic response to recurrent hypoglycemia (2, 3) . However, it remains to be shown whether the association is causal.
In conclusion, persons with T1D with hypoglycemic rates corresponding to daily exposure to hypoglycemia have an increased fraction of asymptomatic events. These persons are also at increased risk for severe hypoglycemia and are characterized by presence of multiple risk factors for severe hypoglycemia. The proportion of asymptomatic hypoglycemia events increases as hypoglycemia awareness decreases; however, the overall rate of hypoglycemia only tends to increase slightly as awareness decreases. In clinical practice, these persons at high risk for hypoglycemia deserve particular attention and efforts to reduce the frequency and fraction of asymptomatic hypoglycemia because such episodes may contribute to the vicious cycle of recurrent hypoglycemia leading to impaired awareness and a greater risk for severe hypoglycemia in T1D.
